The unified social credit code/registration number of Meiya Pharmaceutical Haian Co., Ltd. is 913206210914720885, and the enterprise is in the opening state.
The business scope of Meiya Pharmaceutical Haian Co., Ltd. is: the production and sales of raw materials (cytidine disodium triphosphate, adenosine triphosphate and adenosine cyclophosphate), nucleotide products, feed additives and food additives; Sales of chemical products; Pharmaceutical intermediates, pharmaceutical technology development, technical consultation, technical service and technology transfer; (except for dangerous chemicals and precursor chemicals in the above business scope); Purchase and sale of grain; Acquisition and sale of livestock; Self-management and agency for the import and export of all kinds of goods and technologies (except those restricted or prohibited by the state); Feed and grain sales; The acquisition and sale of local Chinese medicinal materials (except those controlled by the state, ephedra, toxic medicinal materials and endangered medicinal materials); R&D and health food marketing: technology research and development, technology transfer and technology consultation in the field of health food production. (Projects subject to approval according to law can only be operated after approval by relevant departments). In Jiangsu Province, the total registered capital of companies with similar business scope is10344382,000 yuan, and the main capital is concentrated in enterprises with scale of10000-50 million and above, with 4,280 companies. In the province, the registered capital of enterprises is good at present.
View more information and information of Meiya Pharmaceutical Haian Co., Ltd. through Baidu Enterprise Credit.